Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:35958598

Comprehensive FGFR3 alteration-related transcriptomic characterization is involved in immune infiltration and correlated with prognosis and immunotherapy response of bladder cancer.

Ting Xu · Weizhang Xu · Yuxiao Zheng · Xiao Li · Hongzhou Cai · Zicheng Xu · Qing Zou · Bin Yu

Frontiers in immunology · 2022 doi:10.3389/fimmu.2022.931906

Paper

complete

Experiment

complete

Data

partial

Analysis

complete

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:35958598
kind
science-record
content_hash
sha256:1b51e62c2d11c2b9f22542eb3c0d58537622eb45b9b6193a03ab77799c47d7ca
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T18:15:04Z
updated_at
2026-11-01T22:07:14Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Comprehensive FGFR3 alteration-related transcriptomic characterization is involved in immune infiltration and correlated with prognosis and immunotherapy response of bladder cancer.
doi
10.3389/fimmu.2022.931906
pmid
35958598
authors array · 8 items
[0]
Ting Xu
[1]
Weizhang Xu
[2]
Yuxiao Zheng
[3]
Xiao Li
[4]
Hongzhou Cai
[5]
Zicheng Xu
[6]
Qing Zou
[7]
Bin Yu
journal
Frontiers in immunology
year
2022
abstract
Background: Bladder cancer (BC) threatens the health of human beings worldwide because of its high recurrence rate and mortality. As an actionable biomarker, fibroblast growth factor receptor 3 (FGFR3) alterations have been revealed as a vital biomarker and associated with favorable outcomes in BC. However, the comprehensive relationship between the FGFR3 alteration associated gene expression profile and the prognosis of BC remains ambiguous. Materials and Methods: Genomic alteration profile, gene expression data, and related clinical information of BC patients were downloaded from The Cancer Genomics database (TCGA), as a training cohort. Subsequently, the Weighted Gene Co-expression Network Analysis (WGCNA) was conducted to identify the hub modules correlated with FGFR3 alteration. The univariate, multivariate, and least absolute shrinkage and selection operator (LASSO) Cox regression analyses were used to obtain an FGFR3 alteration-related gene (FARG) prognostic signature and FARG-based nomogram. The receiver operating characteristic (ROC) curve analysis was used for evaluation of the ability of prognosis prediction. The FARG signature was validated in four independent datasets, namely, GSE13507, GSE31684, GSE32548, and GSE48075, from Gene Expression Omnibus (GEO). Then, clinical feature association analysis, functional enrichment, genomic alteration enrichment, and tumor environment analysis were conducted to reveal differential clinical and molecular characterizations in different risk groups. Lastly, the treatment response was evaluated in the immunotherapy-related dataset of the IMvigor210 cohort and the frontline chemotherapy dataset of GSE48276, and the chemo-drug sensitivity was estimated via Genomics of Drug Sensitivity in Cancer (GDSC). Results: There were a total of eleven genes (CERCAM, TPST1, OSBPL10, EMP1, CYTH3, NCRNA00201, PCDH10, GAP43, COLQ, DGKB, and SETBP1) identified in the FARG signature, which divided BC patients from the TCGA cohort into high- and low-risk groups. The Kaplan-Meier curve analysis demonstrated that BC patients in the low-risk group have superior overall survival (OS) than those in the high-risk group (median OS: 27.06 months vs. 104.65 months, p < 0.0001). Moreover, the FARG signature not only showed a good performance in prognosis prediction, but also could distinguish patients with different neoplasm disease stages, notably whether patients presented with muscle invasive phenotype. Compared to clinicopathological features, the FARG signature was found to be the only independent prognostic factor, and subsequently, a FARG-based prognostic nomogram was constructed with better ability of prognosis prediction, indicated by area under ROC curve (AUC) values for 1-, 3-, and 5-year OS of 0.69, 0.71, and 0.79, respectively. Underlying the FARG signature, multiple kinds of metabolism- and immune-related signaling pathways were enriched. Genomic alteration enrichment further identified that FGFR3 alterations, especially c.746C>G (p.Ser249Cys), were more prevalent in the low-risk group. Additionally, FARG score was positively correlated with ESTIMATE and TIDE scores, and the low-risk group had abundant enrichment of plasma B cells, CD8+ T cells, CD4+ naive T cells, and helper follicular T cells, implying that patients in the low-risk group were likely to make significant responses to immunotherapy, which was further supported by the analysis in the IMvigor210 cohort as there was a significantly higher response rate among patients with lower FARG scores. The analysis of the GDSC database finally demonstrated that low-risk samples were more sensitive to methotrexate and tipifarnib, whereas those in the high-risk group had higher sensitivities in cisplatin, docetaxel, and paclitaxel, instead. Conclusion: The novel established FARG signature based on a comprehensive FGFR3 alteration-related transcriptomic profile performed well in prognosis prediction and was also correlated with immunotherapy and chemotherapy treatment responses, which had great potential in future clinical applications.
claims array · 2 items
[0] object · 6 fields
id
claim-method
statement
The univariate, multivariate, and least absolute shrinkage and selection operator (LASSO) Cox regression analyses were used to obtain an FGFR3 alteration-related gene (FARG) prognostic signature and FARG-based nomogram.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:35958598
locator
sections[0] "Abstract" paragraph 2
quote
The univariate, multivariate, and least absolute shrinkage and selection operator (LASSO) Cox regression analyses were used to obtain an FGFR3 alteration-related gene (FARG) prognostic signature and FARG-based nomogram.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:35958598
locator
sections[24] "Data availability statement" paragraph 2
quote
In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
null
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:35958598
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE13507
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE13507
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 6 items
[0] object · 15 fields
id
source:pmid:35958598
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.3389/fimmu.2022.931906
sha256
sha256:5241521f293a299e59857961316bd32081ed83c2b184bb626a28713a2c5eb4fc
bytes
67175
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.3389/fimmu.2022.931906
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC9360490
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE13507
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE13507
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE13507
version
null
note
In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.
access_statement_kind
data_availability_statement
sample_accessions array · 256 items
[0]
GSM340537
[1]
GSM340538
[2]
GSM340539
[3]
GSM340540
[4]
GSM340541
[5]
GSM340542
[6]
GSM340543
[7]
GSM340544
[8]
GSM340545
[9]
GSM340546
[10]
GSM340547
[11]
GSM340548
[12]
GSM340549
[13]
GSM340550
[14]
GSM340551
[15]
GSM340552
[16]
GSM340553
[17]
GSM340554
[18]
GSM340555
[19]
GSM340556
[20]
GSM340557
[21]
GSM340558
[22]
GSM340559
[23]
GSM340560
[24]
GSM340561
[25]
GSM340562
[26]
GSM340563
[27]
GSM340564
[28]
GSM340565
[29]
GSM340566
[30]
GSM340567
[31]
GSM340568
[32]
GSM340569
[33]
GSM340570
[34]
GSM340571
[35]
GSM340572
[36]
GSM340573
[37]
GSM340574
[38]
GSM340575
[39]
GSM340576
[40]
GSM340577
[41]
GSM340578
[42]
GSM340579
[43]
GSM340580
[44]
GSM340581
[45]
GSM340582
[46]
GSM340583
[47]
GSM340584
[48]
GSM340585
[49]
GSM340586
[50]
GSM340587
[51]
GSM340588
[52]
GSM340589
[53]
GSM340590
[54]
GSM340591
[55]
GSM340592
[56]
GSM340593
[57]
GSM340594
[58]
GSM340595
[59]
GSM340596
[60]
GSM340597
[61]
GSM340598
[62]
GSM340599
[63]
GSM340600
[64]
GSM340601
[65]
GSM340602
[66]
GSM340603
[67]
GSM340604
[68]
GSM340605
[69]
GSM340606
[70]
GSM340607
[71]
GSM340608
[72]
GSM340609
[73]
GSM340610
[74]
GSM340611
[75]
GSM340612
[76]
GSM340613
[77]
GSM340614
[78]
GSM340615
[79]
GSM340616
[80]
GSM340617
[81]
GSM340618
[82]
GSM340619
[83]
GSM340620
[84]
GSM340621
[85]
GSM340622
[86]
GSM340623
[87]
GSM340624
[88]
GSM340625
[89]
GSM340626
[90]
GSM340627
[91]
GSM340628
[92]
GSM340629
[93]
GSM340630
[94]
GSM340631
[95]
GSM340632
[96]
GSM340633
[97]
GSM340634
[98]
GSM340635
[99]
GSM340636
[100]
GSM340637
[101]
GSM340638
[102]
GSM340639
[103]
GSM340640
[104]
GSM340641
[105]
GSM340642
[106]
GSM340643
[107]
GSM340644
[108]
GSM340645
[109]
GSM340646
[110]
GSM340647
[111]
GSM340648
[112]
GSM340649
[113]
GSM340650
[114]
GSM340651
[115]
GSM340652
[116]
GSM340653
[117]
GSM340654
[118]
GSM340655
[119]
GSM340656
[120]
GSM340657
[121]
GSM340658
[122]
GSM340659
[123]
GSM340660
[124]
GSM340661
[125]
GSM340662
[126]
GSM340663
[127]
GSM340664
[128]
GSM340665
[129]
GSM340666
[130]
GSM340667
[131]
GSM340668
[132]
GSM340669
[133]
GSM340670
[134]
GSM340671
[135]
GSM340672
[136]
GSM340673
[137]
GSM340674
[138]
GSM340675
[139]
GSM340676
[140]
GSM340677
[141]
GSM340678
[142]
GSM340679
[143]
GSM340680
[144]
GSM340681
[145]
GSM340682
[146]
GSM340683
[147]
GSM340684
[148]
GSM340685
[149]
GSM340686
[150]
GSM340687
[151]
GSM340688
[152]
GSM340689
[153]
GSM340690
[154]
GSM340691
[155]
GSM340692
[156]
GSM340693
[157]
GSM340694
[158]
GSM340695
[159]
GSM340696
[160]
GSM340697
[161]
GSM340698
[162]
GSM340699
[163]
GSM340700
[164]
GSM340701
[165]
GSM340702
[166]
GSM340703
[167]
GSM340704
[168]
GSM340705
[169]
GSM340706
[170]
GSM340707
[171]
GSM340708
[172]
GSM340709
[173]
GSM340710
[174]
GSM340711
[175]
GSM340712
[176]
GSM340713
[177]
GSM340714
[178]
GSM340715
[179]
GSM340716
[180]
GSM340717
[181]
GSM340718
[182]
GSM340719
[183]
GSM340720
[184]
GSM340721
[185]
GSM340722
[186]
GSM340723
[187]
GSM340724
[188]
GSM340725
[189]
GSM340726
[190]
GSM340727
[191]
GSM340728
[192]
GSM340729
[193]
GSM340730
[194]
GSM340731
[195]
GSM340732
[196]
GSM340733
[197]
GSM340734
[198]
GSM340735
[199]
GSM340736
[200]
GSM340737
[201]
GSM340738
[202]
GSM340739
[203]
GSM340740
[204]
GSM340741
[205]
GSM340742
[206]
GSM340743
[207]
GSM340744
[208]
GSM340745
[209]
GSM340746
[210]
GSM340747
[211]
GSM340748
[212]
GSM340749
[213]
GSM340750
[214]
GSM340751
[215]
GSM340752
[216]
GSM340753
[217]
GSM340754
[218]
GSM340755
[219]
GSM340756
[220]
GSM340757
[221]
GSM340758
[222]
GSM340759
[223]
GSM340760
[224]
GSM340761
[225]
GSM340762
[226]
GSM340763
[227]
GSM340764
[228]
GSM340765
[229]
GSM340766
[230]
GSM340767
[231]
GSM340768
[232]
GSM340769
[233]
GSM340770
[234]
GSM340771
[235]
GSM340772
[236]
GSM340773
[237]
GSM340774
[238]
GSM340775
[239]
GSM340776
[240]
GSM340777
[241]
GSM340778
[242]
GSM340779
[243]
GSM340780
[244]
GSM340781
[245]
GSM340782
[246]
GSM340783
[247]
GSM340784
[248]
GSM340785
[249]
GSM340786
[250]
GSM340787
[251]
GSM340788
[252]
GSM340789
[253]
GSM340790
[254]
GSM340791
[255]
GSM340792
sample_count
256
group_sizes
null
group_sizes_basis
null
platform
6102
taxon
Homo sapiens
title
Predective Value of Prognosis-Related Gene Expression Study in Primary Bladder Cancer
resolution_checked_at
2026-11-01T15:39:54Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 15 fields
id
data:geo:GSE31684
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31684
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE31684
version
null
note
In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.
access_statement_kind
data_availability_statement
sample_accessions array · 93 items
[0]
GSM786491
[1]
GSM786492
[2]
GSM786493
[3]
GSM786494
[4]
GSM786495
[5]
GSM786496
[6]
GSM786497
[7]
GSM786498
[8]
GSM786499
[9]
GSM786500
[10]
GSM786501
[11]
GSM786502
[12]
GSM786503
[13]
GSM786504
[14]
GSM786505
[15]
GSM786506
[16]
GSM786507
[17]
GSM786508
[18]
GSM786509
[19]
GSM786510
[20]
GSM786511
[21]
GSM786512
[22]
GSM786513
[23]
GSM786514
[24]
GSM786515
[25]
GSM786516
[26]
GSM786517
[27]
GSM786518
[28]
GSM786519
[29]
GSM786520
[30]
GSM786521
[31]
GSM786522
[32]
GSM786523
[33]
GSM786524
[34]
GSM786525
[35]
GSM786526
[36]
GSM786527
[37]
GSM786528
[38]
GSM786529
[39]
GSM786530
[40]
GSM786531
[41]
GSM786532
[42]
GSM786533
[43]
GSM786534
[44]
GSM786535
[45]
GSM786536
[46]
GSM786537
[47]
GSM786538
[48]
GSM786539
[49]
GSM786540
[50]
GSM786541
[51]
GSM786542
[52]
GSM786543
[53]
GSM786544
[54]
GSM786545
[55]
GSM786546
[56]
GSM786547
[57]
GSM786548
[58]
GSM786549
[59]
GSM786550
[60]
GSM786551
[61]
GSM786552
[62]
GSM786553
[63]
GSM786554
[64]
GSM786555
[65]
GSM786556
[66]
GSM786557
[67]
GSM786558
[68]
GSM786559
[69]
GSM786560
[70]
GSM786561
[71]
GSM786562
[72]
GSM786563
[73]
GSM786564
[74]
GSM786565
[75]
GSM786566
[76]
GSM786567
[77]
GSM786568
[78]
GSM786569
[79]
GSM786570
[80]
GSM786571
[81]
GSM786572
[82]
GSM786573
[83]
GSM786574
[84]
GSM786575
[85]
GSM786576
[86]
GSM786577
[87]
GSM786578
[88]
GSM786579
[89]
GSM786580
[90]
GSM786581
[91]
GSM786582
[92]
GSM786583
sample_count
93
group_sizes
null
group_sizes_basis
null
platform
570
taxon
Homo sapiens
title
Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer  
resolution_checked_at
2026-11-01T15:39:54Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[3] object · 15 fields
id
data:geo:GSE32548
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32548
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE32548
version
null
note
In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.
access_statement_kind
data_availability_statement
sample_accessions array · 131 items
[0]
GSM806803
[1]
GSM806804
[2]
GSM806805
[3]
GSM806806
[4]
GSM806807
[5]
GSM806808
[6]
GSM806809
[7]
GSM806810
[8]
GSM806811
[9]
GSM806812
[10]
GSM806813
[11]
GSM806814
[12]
GSM806815
[13]
GSM806816
[14]
GSM806817
[15]
GSM806818
[16]
GSM806819
[17]
GSM806820
[18]
GSM806821
[19]
GSM806822
[20]
GSM806823
[21]
GSM806824
[22]
GSM806825
[23]
GSM806826
[24]
GSM806827
[25]
GSM806828
[26]
GSM806829
[27]
GSM806830
[28]
GSM806831
[29]
GSM806832
[30]
GSM806833
[31]
GSM806834
[32]
GSM806835
[33]
GSM806836
[34]
GSM806837
[35]
GSM806838
[36]
GSM806839
[37]
GSM806840
[38]
GSM806841
[39]
GSM806842
[40]
GSM806843
[41]
GSM806844
[42]
GSM806845
[43]
GSM806846
[44]
GSM806847
[45]
GSM806848
[46]
GSM806849
[47]
GSM806850
[48]
GSM806851
[49]
GSM806852
[50]
GSM806853
[51]
GSM806854
[52]
GSM806855
[53]
GSM806856
[54]
GSM806857
[55]
GSM806858
[56]
GSM806859
[57]
GSM806860
[58]
GSM806861
[59]
GSM806862
[60]
GSM806863
[61]
GSM806864
[62]
GSM806865
[63]
GSM806866
[64]
GSM806867
[65]
GSM806868
[66]
GSM806869
[67]
GSM806870
[68]
GSM806871
[69]
GSM806872
[70]
GSM806873
[71]
GSM806874
[72]
GSM806875
[73]
GSM806876
[74]
GSM806877
[75]
GSM806878
[76]
GSM806879
[77]
GSM806880
[78]
GSM806881
[79]
GSM806882
[80]
GSM806883
[81]
GSM806884
[82]
GSM806885
[83]
GSM806886
[84]
GSM806887
[85]
GSM806888
[86]
GSM806889
[87]
GSM806890
[88]
GSM806891
[89]
GSM806892
[90]
GSM806893
[91]
GSM806894
[92]
GSM806895
[93]
GSM806896
[94]
GSM806897
[95]
GSM806898
[96]
GSM806899
[97]
GSM806900
[98]
GSM806901
[99]
GSM806902
[100]
GSM806903
[101]
GSM806904
[102]
GSM806905
[103]
GSM806906
[104]
GSM806907
[105]
GSM806908
[106]
GSM806909
[107]
GSM806910
[108]
GSM806911
[109]
GSM806912
[110]
GSM806913
[111]
GSM806914
[112]
GSM806915
[113]
GSM806916
[114]
GSM806917
[115]
GSM806918
[116]
GSM806919
[117]
GSM806920
[118]
GSM806921
[119]
GSM806922
[120]
GSM806923
[121]
GSM806924
[122]
GSM806925
[123]
GSM806926
[124]
GSM806927
[125]
GSM806928
[126]
GSM806929
[127]
GSM806930
[128]
GSM806931
[129]
GSM806932
[130]
GSM806933
sample_count
131
group_sizes
null
group_sizes_basis
null
platform
6947
taxon
Homo sapiens
title
Integrated genomic and gene expression profiling identifies two major gene/genomic circuits operating in urothelial carcinoma (gene expression)
resolution_checked_at
2026-11-01T15:39:54Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[4] object · 15 fields
id
data:geo:GSE48075
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE48075
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE48075
version
null
note
In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.
access_statement_kind
data_availability_statement
sample_accessions array · 142 items
[0]
GSM1167333
[1]
GSM1167334
[2]
GSM1167335
[3]
GSM1167336
[4]
GSM1167337
[5]
GSM1167338
[6]
GSM1167339
[7]
GSM1167340
[8]
GSM1167341
[9]
GSM1167342
[10]
GSM1167343
[11]
GSM1167344
[12]
GSM1167345
[13]
GSM1167346
[14]
GSM1167347
[15]
GSM1167348
[16]
GSM1167349
[17]
GSM1167350
[18]
GSM1167351
[19]
GSM1167352
[20]
GSM1167353
[21]
GSM1167354
[22]
GSM1167355
[23]
GSM1167356
[24]
GSM1167357
[25]
GSM1167358
[26]
GSM1167359
[27]
GSM1167360
[28]
GSM1167361
[29]
GSM1167362
[30]
GSM1167363
[31]
GSM1167364
[32]
GSM1167365
[33]
GSM1167366
[34]
GSM1167367
[35]
GSM1167368
[36]
GSM1167369
[37]
GSM1167370
[38]
GSM1167371
[39]
GSM1167372
[40]
GSM1167373
[41]
GSM1167374
[42]
GSM1167375
[43]
GSM1167376
[44]
GSM1167377
[45]
GSM1167378
[46]
GSM1167379
[47]
GSM1167380
[48]
GSM1167381
[49]
GSM1167382
[50]
GSM1167383
[51]
GSM1167384
[52]
GSM1167385
[53]
GSM1167386
[54]
GSM1167387
[55]
GSM1167388
[56]
GSM1167389
[57]
GSM1167390
[58]
GSM1167391
[59]
GSM1167392
[60]
GSM1167393
[61]
GSM1167394
[62]
GSM1167395
[63]
GSM1167396
[64]
GSM1167397
[65]
GSM1167398
[66]
GSM1167399
[67]
GSM1167400
[68]
GSM1167401
[69]
GSM1167402
[70]
GSM1167403
[71]
GSM1167404
[72]
GSM1167405
[73]
GSM1167406
[74]
GSM1167407
[75]
GSM1167408
[76]
GSM1167409
[77]
GSM1167410
[78]
GSM1167411
[79]
GSM1167412
[80]
GSM1167413
[81]
GSM1167414
[82]
GSM1167415
[83]
GSM1167416
[84]
GSM1167417
[85]
GSM1167418
[86]
GSM1167419
[87]
GSM1167420
[88]
GSM1167421
[89]
GSM1167422
[90]
GSM1167423
[91]
GSM1167424
[92]
GSM1167425
[93]
GSM1167426
[94]
GSM1167427
[95]
GSM1167428
[96]
GSM1167429
[97]
GSM1167430
[98]
GSM1167431
[99]
GSM1167432
[100]
GSM1167433
[101]
GSM1167434
[102]
GSM1167435
[103]
GSM1167436
[104]
GSM1167437
[105]
GSM1167438
[106]
GSM1167439
[107]
GSM1167440
[108]
GSM1167441
[109]
GSM1167442
[110]
GSM1167443
[111]
GSM1167444
[112]
GSM1167445
[113]
GSM1167446
[114]
GSM1167447
[115]
GSM1167448
[116]
GSM1167449
[117]
GSM1167450
[118]
GSM1167451
[119]
GSM1167452
[120]
GSM1167453
[121]
GSM1167454
[122]
GSM1167455
[123]
GSM1167456
[124]
GSM1167457
[125]
GSM1167458
[126]
GSM1167459
[127]
GSM1167460
[128]
GSM1167461
[129]
GSM1167462
[130]
GSM1167463
[131]
GSM1167464
[132]
GSM1167465
[133]
GSM1167466
[134]
GSM1167467
[135]
GSM1167468
[136]
GSM1167469
[137]
GSM1167470
[138]
GSM1167471
[139]
GSM1167472
[140]
GSM1167473
[141]
GSM1167474
sample_count
142
group_sizes
null
group_sizes_basis
null
platform
6947
taxon
Homo sapiens
title
Identification of subsets of urothelial carcinoma
resolution_checked_at
2026-11-01T15:39:54Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[5] object · 15 fields
id
data:geo:GSE48276
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE48276
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE48276
version
null
note
In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.
access_statement_kind
data_availability_statement
sample_accessions array · 116 items
[0]
GSM1173901
[1]
GSM1173902
[2]
GSM1173903
[3]
GSM1173904
[4]
GSM1173905
[5]
GSM1173906
[6]
GSM1173907
[7]
GSM1173908
[8]
GSM1173909
[9]
GSM1173910
[10]
GSM1173911
[11]
GSM1173912
[12]
GSM1173913
[13]
GSM1173914
[14]
GSM1173915
[15]
GSM1173916
[16]
GSM1173917
[17]
GSM1173918
[18]
GSM1173919
[19]
GSM1173920
[20]
GSM1173921
[21]
GSM1173922
[22]
GSM1173923
[23]
GSM1173924
[24]
GSM1173925
[25]
GSM1173926
[26]
GSM1173927
[27]
GSM1173928
[28]
GSM1173929
[29]
GSM1173930
[30]
GSM1173931
[31]
GSM1173932
[32]
GSM1173933
[33]
GSM1173934
[34]
GSM1173935
[35]
GSM1173936
[36]
GSM1173937
[37]
GSM1173938
[38]
GSM1173939
[39]
GSM1173940
[40]
GSM1173941
[41]
GSM1173942
[42]
GSM1173943
[43]
GSM1173944
[44]
GSM1173945
[45]
GSM1173946
[46]
GSM1173947
[47]
GSM1173948
[48]
GSM1173949
[49]
GSM1173950
[50]
GSM1173951
[51]
GSM1173952
[52]
GSM1173953
[53]
GSM1173954
[54]
GSM1173955
[55]
GSM1173956
[56]
GSM1173957
[57]
GSM1173968
[58]
GSM1173969
[59]
GSM1173970
[60]
GSM1173971
[61]
GSM1173972
[62]
GSM1173973
[63]
GSM1173974
[64]
GSM1173975
[65]
GSM1173976
[66]
GSM1173977
[67]
GSM1173978
[68]
GSM1173979
[69]
GSM1173980
[70]
GSM1173981
[71]
GSM1173982
[72]
GSM1173983
[73]
GSM1173986
[74]
GSM1173987
[75]
GSM1173988
[76]
GSM1173989
[77]
GSM1173990
[78]
GSM1173991
[79]
GSM1173992
[80]
GSM1173993
[81]
GSM1173994
[82]
GSM1173995
[83]
GSM1173996
[84]
GSM1173997
[85]
GSM1173998
[86]
GSM1173999
[87]
GSM1174000
[88]
GSM1174001
[89]
GSM1174002
[90]
GSM1174003
[91]
GSM1174004
[92]
GSM1174005
[93]
GSM1174006
[94]
GSM1174007
[95]
GSM1174008
[96]
GSM1174009
[97]
GSM1174010
[98]
GSM1174011
[99]
GSM1174012
[100]
GSM1174013
[101]
GSM1174014
[102]
GSM1174015
[103]
GSM1174016
[104]
GSM1174017
[105]
GSM1174018
[106]
GSM1174019
[107]
GSM1174020
[108]
GSM1174021
[109]
GSM1174022
[110]
GSM1174023
[111]
GSM1174024
[112]
GSM1174025
[113]
GSM1174026
[114]
GSM1174027
[115]
GSM1174028
sample_count
116
group_sizes
null
group_sizes_basis
null
platform
14951
taxon
Homo sapiens
title
Gene expression profiling of urothelial carcinoma
resolution_checked_at
2026-11-01T15:39:54Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
gaps array · 10 items
[0]
asset:data:geo:GSE13507 not downloaded
[1]
asset:data:geo:GSE13507 licence not read
[2]
asset:data:geo:GSE31684 not downloaded
[3]
asset:data:geo:GSE31684 licence not read
[4]
asset:data:geo:GSE32548 not downloaded
[5]
asset:data:geo:GSE32548 licence not read
[6]
asset:data:geo:GSE48075 not downloaded
[7]
asset:data:geo:GSE48075 licence not read
[8]
asset:data:geo:GSE48276 not downloaded
[9]
asset:data:geo:GSE48276 licence not read
analysis object · 4 fields
state
complete
methods array · 4 items
[0] object · 10 fields
id
method-1
family
survival_analysis
specific
cox_proportional_hazards
label
Survival analysis
dsl_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
1
band
verbatim
quote
The univariate, multivariate, and least absolute shrinkage and selection operator (LASSO) Cox regression analyses were used to obtain an FGFR3 alteration-related gene (FARG) prognostic signature and FARG-based nomogram.
[1] object · 10 fields
id
method-2
family
survival_analysis
specific
kaplan_meier
label
Survival analysis
dsl_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.7
band
medium
quote
Kaplan-Meier
[2] object · 10 fields
id
method-3
family
survival_analysis
specific
log_rank_test
label
Survival analysis
dsl_operations array · 1 item
[0]
logrank_test
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.8
band
high
quote
log rank
[3] object · 10 fields
id
method-4
family
diagnostic_evaluation
specific
roc
label
Diagnostic test evaluation
dsl_operations array · 6 items
[0]
confusion_counts
[1]
roc_curve
[2]
sensitivity_specificity
[3]
solve_confusion_matrix
[4]
classification_metrics
[5]
published_precision_envelope
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
reference_standard_and_test
evidence object · 3 fields
score
0.7
band
medium
quote
ROC curve
targets array · 0 items
gaps array · 0 items
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 5 items
[0]
GSE13507
[1]
GSE31684
[2]
GSE32548
[3]
GSE48075
[4]
GSE48276
resolved_accessions array · 5 items
[0]
GSE13507
[1]
GSE31684
[2]
GSE32548
[3]
GSE48075
[4]
GSE48276
statements array · 1 item
[0]
In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.
basis
The paper names GSE13507, GSE31684, GSE32548, GSE48075, GSE48276 in Gene Expression Omnibus (GEO) database and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 1 item
[0]
cox_ph
assets array · 2 items
[0]
source:pmid:35958598
[1]
data:geo:GSE13507
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE13507
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-11-01T17:59:29Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
5
usage object · 3 fields
prompt_tokens
18404
completion_tokens
3201
cached_tokens
264
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:35958598
type
paper
label
pmid:35958598
[1] object · 3 fields
id
source:pmid:35958598
type
manuscript
label
PMID 35958598 full text
[2] object · 3 fields
id
data:geo:GSE13507
type
dataset
label
GEO GSE13507
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:35958598
type
paper
label
pmid:35958598
[1] object · 3 fields
id
source:pmid:35958598
type
manuscript
label
PMID 35958598 full text
[2] object · 3 fields
id
data:geo:GSE13507
type
dataset
label
GEO GSE13507
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-35958598
type
extraction
used array · 1 item
[0]
source:pmid:35958598
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE13507
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE13507
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:35958598
parent_hash
sha256:48876630e560d0c401532e3d37777a3d12069e88fac1b0b20bd725989cd37c41
fork_of
null
gaps array · 14 items
[0]
asset:data:geo:GSE13507 licence not read
[1]
asset:data:geo:GSE13507 not downloaded
[2]
asset:data:geo:GSE31684 licence not read
[3]
asset:data:geo:GSE31684 not downloaded
[4]
asset:data:geo:GSE32548 licence not read
[5]
asset:data:geo:GSE32548 not downloaded
[6]
asset:data:geo:GSE48075 licence not read
[7]
asset:data:geo:GSE48075 not downloaded
[8]
asset:data:geo:GSE48276 licence not read
[9]
asset:data:geo:GSE48276 not downloaded
[10]
execution.not_run
[11]
review.human_critique
[12]
review.independent_reader
[13]
review.machine_critique
assays array · 1 item
[0] object · 11 fields
role
analysis
definition_id
survival_analysis
definition_version
f2132e96ae6c7a4e
required_operations array · 1 item
[0]
cox_ph
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
The univariate, multivariate, and least absolute shrinkage and selection operator (LASSO) Cox regression analyses were used to obtain an FGFR3 alteration-related gene (FARG) prognostic signature and FARG-based nomogram.
order_basis
analysis_only
id
assay:1
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:35958598", "kind": "science-record", "revision": 4, "content_hash": "sha256:1b51e62c2d11c2b9f22542eb3c0d58537622eb45b9b6193a03ab77799c47d7ca", "created_at": "2026-11-01T18:15:04Z", "updated_at": "2026-11-01T22:07:14Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Comprehensive FGFR3 alteration-related transcriptomic characterization is involved in immune infiltration and correlated with prognosis and immunotherapy response of bladder cancer.", "doi": "10.3389/fimmu.2022.931906", "pmid": "35958598", "authors": ["Ting Xu", "Weizhang Xu", "Yuxiao Zheng", "Xiao Li", "Hongzhou Cai", "Zicheng Xu", "Qing Zou", "Bin Yu"], "journal": "Frontiers in immunology", "year": 2022, "abstract": "Background: Bladder cancer (BC) threatens the health of human beings worldwide because of its high recurrence rate and mortality. As an actionable biomarker, fibroblast growth factor receptor 3 (FGFR3) alterations have been revealed as a vital biomarker and associated with favorable outcomes in BC. However, the comprehensive relationship between the FGFR3 alteration associated gene expression profile and the prognosis of BC remains ambiguous.\nMaterials and Methods: Genomic alteration profile, gene expression data, and related clinical information of BC patients were downloaded from The Cancer Genomics database (TCGA), as a training cohort. Subsequently, the Weighted Gene Co-expression Network Analysis (WGCNA) was conducted to identify the hub modules correlated with FGFR3 alteration. The univariate, multivariate, and least absolute shrinkage and selection operator (LASSO) Cox regression analyses were used to obtain an FGFR3 alteration-related gene (FARG) prognostic signature and FARG-based nomogram. The receiver operating characteristic (ROC) curve analysis was used for evaluation of the ability of prognosis prediction. The FARG signature was validated in four independent datasets, namely, GSE13507, GSE31684, GSE32548, and GSE48075, from Gene Expression Omnibus (GEO). Then, clinical feature association analysis, functional enrichment, genomic alteration enrichment, and tumor environment analysis were conducted to reveal differential clinical and molecular characterizations in different risk groups. Lastly, the treatment response was evaluated in the immunotherapy-related dataset of the IMvigor210 cohort and the frontline chemotherapy dataset of GSE48276, and the chemo-drug sensitivity was estimated via Genomics of Drug Sensitivity in Cancer (GDSC).\nResults: There were a total of eleven genes (CERCAM, TPST1, OSBPL10, EMP1, CYTH3, NCRNA00201, PCDH10, GAP43, COLQ, DGKB, and SETBP1) identified in the FARG signature, which divided BC patients from the TCGA cohort into high- and low-risk groups. The Kaplan-Meier curve analysis demonstrated that BC patients in the low-risk group have superior overall survival (OS) than those in the high-risk group (median OS: 27.06 months vs. 104.65 months, p < 0.0001). Moreover, the FARG signature not only showed a good performance in prognosis prediction, but also could distinguish patients with different neoplasm disease stages, notably whether patients presented with muscle invasive phenotype. Compared to clinicopathological features, the FARG signature was found to be the only independent prognostic factor, and subsequently, a FARG-based prognostic nomogram was constructed with better ability of prognosis prediction, indicated by area under ROC curve (AUC) values for 1-, 3-, and 5-year OS of 0.69, 0.71, and 0.79, respectively. Underlying the FARG signature, multiple kinds of metabolism- and immune-related signaling pathways were enriched. Genomic alteration enrichment further identified that FGFR3 alterations, especially c.746C>G (p.Ser249Cys), were more prevalent in the low-risk group. Additionally, FARG score was positively correlated with ESTIMATE and TIDE scores, and the low-risk group had abundant enrichment of plasma B cells, CD8+ T cells, CD4+ naive T cells, and helper follicular T cells, implying that patients in the low-risk group were likely to make significant responses to immunotherapy, which was further supported by the analysis in the IMvigor210 cohort as there was a significantly higher response rate among patients with lower FARG scores. The analysis of the GDSC database finally demonstrated that low-risk samples were more sensitive to methotrexate and tipifarnib, whereas those in the high-risk group had higher sensitivities in cisplatin, docetaxel, and paclitaxel, instead.\nConclusion: The novel established FARG signature based on a comprehensive FGFR3 alteration-related transcriptomic profile performed well in prognosis prediction and was also correlated with immunotherapy and chemotherapy treatment responses, which had great potential in future clinical applications.", "claims": [{"id": "claim-method", "statement": "The univariate, multivariate, and least absolute shrinkage and selection operator (LASSO) Cox regression analyses were used to obtain an FGFR3 alteration-related gene (FARG) prognostic signature and FARG-based nomogram.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:35958598", "locator": "sections[0] \"Abstract\" paragraph 2", "quote": "The univariate, multivariate, and least absolute shrinkage and selection operator (LASSO) Cox regression analyses were used to obtain an FGFR3 alteration-related gene (FARG) prognostic signature and FARG-based nomogram."}], "state": "complete"}, {"id": "claim-data-access", "statement": "In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:35958598", "locator": "sections[24] \"Data availability statement\" paragraph 2", "quote": "In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:35958598"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE13507"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE13507"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:35958598", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.3389/fimmu.2022.931906", "sha256": "sha256:5241521f293a299e59857961316bd32081ed83c2b184bb626a28713a2c5eb4fc", "bytes": 67175, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.3389/fimmu.2022.931906", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC9360490", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE13507", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE13507", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE13507", "version": null, "note": "In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM340537", "GSM340538", "GSM340539", "GSM340540", "GSM340541", "GSM340542", "GSM340543", "GSM340544", "GSM340545", "GSM340546", "GSM340547", "GSM340548", "GSM340549", "GSM340550", "GSM340551", "GSM340552", "GSM340553", "GSM340554", "GSM340555", "GSM340556", "GSM340557", "GSM340558", "GSM340559", "GSM340560", "GSM340561", "GSM340562", "GSM340563", "GSM340564", "GSM340565", "GSM340566", "GSM340567", "GSM340568", "GSM340569", "GSM340570", "GSM340571", "GSM340572", "GSM340573", "GSM340574", "GSM340575", "GSM340576", "GSM340577", "GSM340578", "GSM340579", "GSM340580", "GSM340581", "GSM340582", "GSM340583", "GSM340584", "GSM340585", "GSM340586", "GSM340587", "GSM340588", "GSM340589", "GSM340590", "GSM340591", "GSM340592", "GSM340593", "GSM340594", "GSM340595", "GSM340596", "GSM340597", "GSM340598", "GSM340599", "GSM340600", "GSM340601", "GSM340602", "GSM340603", "GSM340604", "GSM340605", "GSM340606", "GSM340607", "GSM340608", "GSM340609", "GSM340610", "GSM340611", "GSM340612", "GSM340613", "GSM340614", "GSM340615", "GSM340616", "GSM340617", "GSM340618", "GSM340619", "GSM340620", "GSM340621", "GSM340622", "GSM340623", "GSM340624", "GSM340625", "GSM340626", "GSM340627", "GSM340628", "GSM340629", "GSM340630", "GSM340631", "GSM340632", "GSM340633", "GSM340634", "GSM340635", "GSM340636", "GSM340637", "GSM340638", "GSM340639", "GSM340640", "GSM340641", "GSM340642", "GSM340643", "GSM340644", "GSM340645", "GSM340646", "GSM340647", "GSM340648", "GSM340649", "GSM340650", "GSM340651", "GSM340652", "GSM340653", "GSM340654", "GSM340655", "GSM340656", "GSM340657", "GSM340658", "GSM340659", "GSM340660", "GSM340661", "GSM340662", "GSM340663", "GSM340664", "GSM340665", "GSM340666", "GSM340667", "GSM340668", "GSM340669", "GSM340670", "GSM340671", "GSM340672", "GSM340673", "GSM340674", "GSM340675", "GSM340676", "GSM340677", "GSM340678", "GSM340679", "GSM340680", "GSM340681", "GSM340682", "GSM340683", "GSM340684", "GSM340685", "GSM340686", "GSM340687", "GSM340688", "GSM340689", "GSM340690", "GSM340691", "GSM340692", "GSM340693", "GSM340694", "GSM340695", "GSM340696", "GSM340697", "GSM340698", "GSM340699", "GSM340700", "GSM340701", "GSM340702", "GSM340703", "GSM340704", "GSM340705", "GSM340706", "GSM340707", "GSM340708", "GSM340709", "GSM340710", "GSM340711", "GSM340712", "GSM340713", "GSM340714", "GSM340715", "GSM340716", "GSM340717", "GSM340718", "GSM340719", "GSM340720", "GSM340721", "GSM340722", "GSM340723", "GSM340724", "GSM340725", "GSM340726", "GSM340727", "GSM340728", "GSM340729", "GSM340730", "GSM340731", "GSM340732", "GSM340733", "GSM340734", "GSM340735", "GSM340736", "GSM340737", "GSM340738", "GSM340739", "GSM340740", "GSM340741", "GSM340742", "GSM340743", "GSM340744", "GSM340745", "GSM340746", "GSM340747", "GSM340748", "GSM340749", "GSM340750", "GSM340751", "GSM340752", "GSM340753", "GSM340754", "GSM340755", "GSM340756", "GSM340757", "GSM340758", "GSM340759", "GSM340760", "GSM340761", "GSM340762", "GSM340763", "GSM340764", "GSM340765", "GSM340766", "GSM340767", "GSM340768", "GSM340769", "GSM340770", "GSM340771", "GSM340772", "GSM340773", "GSM340774", "GSM340775", "GSM340776", "GSM340777", "GSM340778", "GSM340779", "GSM340780", "GSM340781", "GSM340782", "GSM340783", "GSM340784", "GSM340785", "GSM340786", "GSM340787", "GSM340788", "GSM340789", "GSM340790", "GSM340791", "GSM340792"], "sample_count": 256, "group_sizes": null, "group_sizes_basis": null, "platform": "6102", "taxon": "Homo sapiens", "title": "Predective Value of Prognosis-Related Gene Expression Study in Primary Bladder Cancer", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "data:geo:GSE31684", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31684", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE31684", "version": null, "note": "In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM786491", "GSM786492", "GSM786493", "GSM786494", "GSM786495", "GSM786496", "GSM786497", "GSM786498", "GSM786499", "GSM786500", "GSM786501", "GSM786502", "GSM786503", "GSM786504", "GSM786505", "GSM786506", "GSM786507", "GSM786508", "GSM786509", "GSM786510", "GSM786511", "GSM786512", "GSM786513", "GSM786514", "GSM786515", "GSM786516", "GSM786517", "GSM786518", "GSM786519", "GSM786520", "GSM786521", "GSM786522", "GSM786523", "GSM786524", "GSM786525", "GSM786526", "GSM786527", "GSM786528", "GSM786529", "GSM786530", "GSM786531", "GSM786532", "GSM786533", "GSM786534", "GSM786535", "GSM786536", "GSM786537", "GSM786538", "GSM786539", "GSM786540", "GSM786541", "GSM786542", "GSM786543", "GSM786544", "GSM786545", "GSM786546", "GSM786547", "GSM786548", "GSM786549", "GSM786550", "GSM786551", "GSM786552", "GSM786553", "GSM786554", "GSM786555", "GSM786556", "GSM786557", "GSM786558", "GSM786559", "GSM786560", "GSM786561", "GSM786562", "GSM786563", "GSM786564", "GSM786565", "GSM786566", "GSM786567", "GSM786568", "GSM786569", "GSM786570", "GSM786571", "GSM786572", "GSM786573", "GSM786574", "GSM786575", "GSM786576", "GSM786577", "GSM786578", "GSM786579", "GSM786580", "GSM786581", "GSM786582", "GSM786583"], "sample_count": 93, "group_sizes": null, "group_sizes_basis": null, "platform": "570", "taxon": "Homo sapiens", "title": "Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer  ", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "data:geo:GSE32548", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32548", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE32548", "version": null, "note": "In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM806803", "GSM806804", "GSM806805", "GSM806806", "GSM806807", "GSM806808", "GSM806809", "GSM806810", "GSM806811", "GSM806812", "GSM806813", "GSM806814", "GSM806815", "GSM806816", "GSM806817", "GSM806818", "GSM806819", "GSM806820", "GSM806821", "GSM806822", "GSM806823", "GSM806824", "GSM806825", "GSM806826", "GSM806827", "GSM806828", "GSM806829", "GSM806830", "GSM806831", "GSM806832", "GSM806833", "GSM806834", "GSM806835", "GSM806836", "GSM806837", "GSM806838", "GSM806839", "GSM806840", "GSM806841", "GSM806842", "GSM806843", "GSM806844", "GSM806845", "GSM806846", "GSM806847", "GSM806848", "GSM806849", "GSM806850", "GSM806851", "GSM806852", "GSM806853", "GSM806854", "GSM806855", "GSM806856", "GSM806857", "GSM806858", "GSM806859", "GSM806860", "GSM806861", "GSM806862", "GSM806863", "GSM806864", "GSM806865", "GSM806866", "GSM806867", "GSM806868", "GSM806869", "GSM806870", "GSM806871", "GSM806872", "GSM806873", "GSM806874", "GSM806875", "GSM806876", "GSM806877", "GSM806878", "GSM806879", "GSM806880", "GSM806881", "GSM806882", "GSM806883", "GSM806884", "GSM806885", "GSM806886", "GSM806887", "GSM806888", "GSM806889", "GSM806890", "GSM806891", "GSM806892", "GSM806893", "GSM806894", "GSM806895", "GSM806896", "GSM806897", "GSM806898", "GSM806899", "GSM806900", "GSM806901", "GSM806902", "GSM806903", "GSM806904", "GSM806905", "GSM806906", "GSM806907", "GSM806908", "GSM806909", "GSM806910", "GSM806911", "GSM806912", "GSM806913", "GSM806914", "GSM806915", "GSM806916", "GSM806917", "GSM806918", "GSM806919", "GSM806920", "GSM806921", "GSM806922", "GSM806923", "GSM806924", "GSM806925", "GSM806926", "GSM806927", "GSM806928", "GSM806929", "GSM806930", "GSM806931", "GSM806932", "GSM806933"], "sample_count": 131, "group_sizes": null, "group_sizes_basis": null, "platform": "6947", "taxon": "Homo sapiens", "title": "Integrated genomic and gene expression profiling identifies two major gene/genomic circuits operating in urothelial carcinoma (gene expression)", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "data:geo:GSE48075", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE48075", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE48075", "version": null, "note": "In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM1167333", "GSM1167334", "GSM1167335", "GSM1167336", "GSM1167337", "GSM1167338", "GSM1167339", "GSM1167340", "GSM1167341", "GSM1167342", "GSM1167343", "GSM1167344", "GSM1167345", "GSM1167346", "GSM1167347", "GSM1167348", "GSM1167349", "GSM1167350", "GSM1167351", "GSM1167352", "GSM1167353", "GSM1167354", "GSM1167355", "GSM1167356", "GSM1167357", "GSM1167358", "GSM1167359", "GSM1167360", "GSM1167361", "GSM1167362", "GSM1167363", "GSM1167364", "GSM1167365", "GSM1167366", "GSM1167367", "GSM1167368", "GSM1167369", "GSM1167370", "GSM1167371", "GSM1167372", "GSM1167373", "GSM1167374", "GSM1167375", "GSM1167376", "GSM1167377", "GSM1167378", "GSM1167379", "GSM1167380", "GSM1167381", "GSM1167382", "GSM1167383", "GSM1167384", "GSM1167385", "GSM1167386", "GSM1167387", "GSM1167388", "GSM1167389", "GSM1167390", "GSM1167391", "GSM1167392", "GSM1167393", "GSM1167394", "GSM1167395", "GSM1167396", "GSM1167397", "GSM1167398", "GSM1167399", "GSM1167400", "GSM1167401", "GSM1167402", "GSM1167403", "GSM1167404", "GSM1167405", "GSM1167406", "GSM1167407", "GSM1167408", "GSM1167409", "GSM1167410", "GSM1167411", "GSM1167412", "GSM1167413", "GSM1167414", "GSM1167415", "GSM1167416", "GSM1167417", "GSM1167418", "GSM1167419", "GSM1167420", "GSM1167421", "GSM1167422", "GSM1167423", "GSM1167424", "GSM1167425", "GSM1167426", "GSM1167427", "GSM1167428", "GSM1167429", "GSM1167430", "GSM1167431", "GSM1167432", "GSM1167433", "GSM1167434", "GSM1167435", "GSM1167436", "GSM1167437", "GSM1167438", "GSM1167439", "GSM1167440", "GSM1167441", "GSM1167442", "GSM1167443", "GSM1167444", "GSM1167445", "GSM1167446", "GSM1167447", "GSM1167448", "GSM1167449", "GSM1167450", "GSM1167451", "GSM1167452", "GSM1167453", "GSM1167454", "GSM1167455", "GSM1167456", "GSM1167457", "GSM1167458", "GSM1167459", "GSM1167460", "GSM1167461", "GSM1167462", "GSM1167463", "GSM1167464", "GSM1167465", "GSM1167466", "GSM1167467", "GSM1167468", "GSM1167469", "GSM1167470", "GSM1167471", "GSM1167472", "GSM1167473", "GSM1167474"], "sample_count": 142, "group_sizes": null, "group_sizes_basis": null, "platform": "6947", "taxon": "Homo sapiens", "title": "Identification of subsets of urothelial carcinoma", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "data:geo:GSE48276", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE48276", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE48276", "version": null, "note": "In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM1173901", "GSM1173902", "GSM1173903", "GSM1173904", "GSM1173905", "GSM1173906", "GSM1173907", "GSM1173908", "GSM1173909", "GSM1173910", "GSM1173911", "GSM1173912", "GSM1173913", "GSM1173914", "GSM1173915", "GSM1173916", "GSM1173917", "GSM1173918", "GSM1173919", "GSM1173920", "GSM1173921", "GSM1173922", "GSM1173923", "GSM1173924", "GSM1173925", "GSM1173926", "GSM1173927", "GSM1173928", "GSM1173929", "GSM1173930", "GSM1173931", "GSM1173932", "GSM1173933", "GSM1173934", "GSM1173935", "GSM1173936", "GSM1173937", "GSM1173938", "GSM1173939", "GSM1173940", "GSM1173941", "GSM1173942", "GSM1173943", "GSM1173944", "GSM1173945", "GSM1173946", "GSM1173947", "GSM1173948", "GSM1173949", "GSM1173950", "GSM1173951", "GSM1173952", "GSM1173953", "GSM1173954", "GSM1173955", "GSM1173956", "GSM1173957", "GSM1173968", "GSM1173969", "GSM1173970", "GSM1173971", "GSM1173972", "GSM1173973", "GSM1173974", "GSM1173975", "GSM1173976", "GSM1173977", "GSM1173978", "GSM1173979", "GSM1173980", "GSM1173981", "GSM1173982", "GSM1173983", "GSM1173986", "GSM1173987", "GSM1173988", "GSM1173989", "GSM1173990", "GSM1173991", "GSM1173992", "GSM1173993", "GSM1173994", "GSM1173995", "GSM1173996", "GSM1173997", "GSM1173998", "GSM1173999", "GSM1174000", "GSM1174001", "GSM1174002", "GSM1174003", "GSM1174004", "GSM1174005", "GSM1174006", "GSM1174007", "GSM1174008", "GSM1174009", "GSM1174010", "GSM1174011", "GSM1174012", "GSM1174013", "GSM1174014", "GSM1174015", "GSM1174016", "GSM1174017", "GSM1174018", "GSM1174019", "GSM1174020", "GSM1174021", "GSM1174022", "GSM1174023", "GSM1174024", "GSM1174025", "GSM1174026", "GSM1174027", "GSM1174028"], "sample_count": 116, "group_sizes": null, "group_sizes_basis": null, "platform": "14951", "taxon": "Homo sapiens", "title": "Gene expression profiling of urothelial carcinoma", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:GSE13507 not downloaded", "asset:data:geo:GSE13507 licence not read", "asset:data:geo:GSE31684 not downloaded", "asset:data:geo:GSE31684 licence not read", "asset:data:geo:GSE32548 not downloaded", "asset:data:geo:GSE32548 licence not read", "asset:data:geo:GSE48075 not downloaded", "asset:data:geo:GSE48075 licence not read", "asset:data:geo:GSE48276 not downloaded", "asset:data:geo:GSE48276 licence not read"]}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "The univariate, multivariate, and least absolute shrinkage and selection operator (LASSO) Cox regression analyses were used to obtain an FGFR3 alteration-related gene (FARG) prognostic signature and FARG-based nomogram."}}, {"id": "method-2", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.7, "band": "medium", "quote": "Kaplan-Meier"}}, {"id": "method-3", "family": "survival_analysis", "specific": "log_rank_test", "label": "Survival analysis", "dsl_operations": ["logrank_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "log rank"}}, {"id": "method-4", "family": "diagnostic_evaluation", "specific": "roc", "label": "Diagnostic test evaluation", "dsl_operations": ["confusion_counts", "roc_curve", "sensitivity_specificity", "solve_confusion_matrix", "classification_metrics", "published_precision_envelope"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["reference_standard_and_test"], "evidence": {"score": 0.7, "band": "medium", "quote": "ROC curve"}}], "targets": [], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["cox_ph"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE13507", "GSE31684", "GSE32548", "GSE48075", "GSE48276"], "resolved_accessions": ["GSE13507", "GSE31684", "GSE32548", "GSE48075", "GSE48276"], "statements": ["In the present study, publicly available datasets, including training group of TCGA-BC cohort (MSK/TCGA, 2020, https://www.cbioportal.org/study/summary?id=blca_msk_tcga_2020) and validation groups of GSE13507, GSE31684, GSE32548, GSE48075 datasets from GEO database (http://www.ncbi.nlm.nih.gov/geo/), were analyzed for construction of prognostic signature. The IMvigor210 cohort of BC patients receiving immunotherapy was retrieved from the following website: https://clinicaltrials.gov/ct2/show/NCT02108652. The GSE48276 dataset was downloaded from the GEO for chemotherapy response evaluation."], "basis": "The paper names GSE13507, GSE31684, GSE32548, GSE48075, GSE48276 in Gene Expression Omnibus (GEO) database and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["cox_ph"], "assets": ["source:pmid:35958598", "data:geo:GSE13507"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE13507"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T17:59:29Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 5, "usage": {"prompt_tokens": 18404, "completion_tokens": 3201, "cached_tokens": 264}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:35958598", "type": "paper", "label": "pmid:35958598"}, {"id": "source:pmid:35958598", "type": "manuscript", "label": "PMID 35958598 full text"}, {"id": "data:geo:GSE13507", "type": "dataset", "label": "GEO GSE13507"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:35958598", "type": "paper", "label": "pmid:35958598"}, {"id": "source:pmid:35958598", "type": "manuscript", "label": "PMID 35958598 full text"}, {"id": "data:geo:GSE13507", "type": "dataset", "label": "GEO GSE13507"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-35958598", "type": "extraction", "used": ["source:pmid:35958598"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE13507", "type": "accession_resolution", "used": ["data:geo:GSE13507"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:35958598", "parent_hash": "sha256:48876630e560d0c401532e3d37777a3d12069e88fac1b0b20bd725989cd37c41", "fork_of": null, "generation": 3}, "gaps": ["asset:data:geo:GSE13507 licence not read", "asset:data:geo:GSE13507 not downloaded", "asset:data:geo:GSE31684 licence not read", "asset:data:geo:GSE31684 not downloaded", "asset:data:geo:GSE32548 licence not read", "asset:data:geo:GSE32548 not downloaded", "asset:data:geo:GSE48075 licence not read", "asset:data:geo:GSE48075 not downloaded", "asset:data:geo:GSE48276 licence not read", "asset:data:geo:GSE48276 not downloaded", "execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["cox_ph"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["The univariate, multivariate, and least absolute shrinkage and selection operator (LASSO) Cox regression analyses were used to obtain an FGFR3 alteration-related gene (FARG) prognostic signature and FARG-based nomogram."], "order_basis": "analysis_only", "id": "assay:1"}]}